Dandan Dong

Dandan Dong currently serves as a Venture Partner at TCGX and a Board Member at InnoCare Pharma, with prior experience as Chief Business Officer at Arrivent Biopharma and Chief Business Officer and Board Member at VISEN Pharmaceuticals. Dandan co-founded RareStone Group and held the role of Managing Director at Vivo Capital for nearly a decade, along with consulting experience at Vivo Ventures. Educational background includes a Ph.D. in Molecular Microbiology from Fudan University, a Bachelor's degree in Biotechnology from Sichuan University, and pre-doctoral training in pathology at New York Medicine Jobs.